Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeBaylis MedicalVersaCross® Large Access Solution in Canada: 1st Clinical Case

VersaCross® Large Access Solution in Canada: 1st Clinical Case

Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution in Canada, to perform a Left Atrial Appendage Closure (LAAC) procedure.

The new solution includes the world’s first 3-in-1 radiofrequency (RF) wire paired with a seamless shapeable dilator designed to optimize tissue dilation for large sheath procedures including LAAC, transcatheter mitral valve repair, RF ablation, and several emerging left sided therapies.

 

Dr. Jacqueline Saw, a leading Interventional Cardiologist in Vancouver, BC, Canada, performed the first Canadian in-human cases with use of the VersaCross Large Access Solution during a left atrial appendage closure procedure, using the Amplatzer™ Amulet™ Occluder by Abbott. Dr. Saw also successfully completed a LAAC procedure using the Boston Scientific WATCHMAN™ implant, with the new solution.

“When getting to the left atrium for my LAAC procedure, speed and simplicity are key. The new VersaCross Large Access Solution allows me to simplify and expedite the procedure for delivering a LAAC sheath into the LA,” said Dr. Saw.  “The seamless dilator design optimizes tissue dilation, making crossing the septum smooth like butter.”

The new solution features a seamless large access transseptal dilator with a sleek profile and no dilator-sheath transition; the device optimizes tissue dilation for large sheath access at both the femoral vein and through the atrial septum. After dilation, the 0.035″ RF wire is instantly deployed and facilitates seamless delivery of large bore therapeutic sheaths to the left atrial appendage.

The included 3-in-1 wire features Baylis’ proprietary RF puncture technology. The electrode-tipped wire can easily start at the SVC, perform RF transseptal puncture, and act as an 0.035″ exchange wire in the left atrium, without the need for device exchanges.

“Building upon the successful launch of the VersaCross RF Transseptal Solution, the VersaCross Large Access Solution continues to address emerging patient and physician needs specific to large sheath procedures,” said John Hanley, Regional Vice President, Canada and Asia-Pacific at Baylis. “We believe the simplicity, efficiency, and ease of use of the VersaCross Large Access Solution will set a new standard of care across all large bore therapy procedures.”

The addition of the VersaCross Large Access Solution enables the delivery of a broader range of therapy devices for electrophysiology and interventional cardiology procedures.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy